semaglutide news october 16 2025 The FDA has approved Wegovy (semaglutide) as a treatment for metabolic-associated steatohepatitis (MASH) with moderate-to-advanced scarring, a serious liver condition affecting approximately 6% of US adults. Key highlights of drug development program Semaglutide: Shedding pounds, weighing risks

Studies tell us that, mechanistically, semaglutide works to: Reduce appetite and hunger signaling Steady blood sugar Slow the rate at which your food out of your stomach and into your small intestine, making you feel fuller longer All of which assist with changing your behaviors such that you consume fewer calories over time

Appetite Regulation GLP-1 tells your brain you feel full, helping reduce overeating

While oral forms of semaglutide currently show less total weight loss than injectables in clinical trials, the improved absorption of sublingual drops makes them a powerful and viable option for many individuals

GLP-1s also provide several other important health benefits: Better blood sugar control: This is especially helpful for people with prediabetes, as it may prevent progression to type 2 diabetes

The choice of laser treatment for tattoo removal is made depending on your skin type and the color of your tattoo

Because the drugs act on powerful metabolic levers, they've also since proven useful against obesity, heart disease, sleep apnea, as well as potentially addiction and now cancer